Shares of Rennova Health, Inc. (NASDAQ:RNVA) have moved -84.34% so far this year and they are now -97.76% from where they were around this time last year.
Over the last six months the stock has moved -87.00%, while it has moved -78.33% over the last quarter. Over the last week and the last one month, the stock has moved -38.09% and -60.26%, respectively.
The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction. Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend. The market is approaching oversold territory. Be watchful of a trend reversal.
Recently, Rennova Health, Inc. (NASDAQ:RNVA) announces the postponement of its Special Meeting of stockholders that was to have taken place originally on May 19, 2017, and which was subsequently postponed to May 26, 2017. The second postponement is necessary because a quorum of shares represented at the meeting continues not to be achieved. The new date for the Special Meeting is June 2, 2017 at 11:00 a.m. Eastern time and it will take place at the offices of Shutts & Bowen LLP, 525 Okeechobee Boulevard, Suite 1100, West Palm Beach, FL 33401. The record date of April 21, 2017 remains unchanged.
Studying the stock’s moving averages shows its 20-Day Simple Moving Average to be $-41.80% while 50-Day Simple Moving Average is $-64.83% and 200-Day Simple Moving Average is $-88.44%.
The stock has declined to a low of $-4.18% over the last 50 days and jumped to a high of $-82.19% over the same period. However, the stock’s price range over the last 12 months is a high of $-98.88% and a low of $-4.18%.
Analysts tracking Rennova Health, Inc. have an average recommendation of 3.00 on its stock. For clarity, recommendation of 1 implies STRONG BUY, 3 implies HOLD and 5 implies SELL.
The stock is currently trading at $0.39, but it should be trading at $555.00 by the end of the next 12 months according to analysts. The current stock price implies the company has a dividend yield of -.
The stock’s average volume, which is the average of three months, is 909.54K, while its relative volume is 0.44.
Insiders own 0.30% of Rennova Health, Inc., while institutional investors own 1.30% of the company.
Of the company’s 8.00M shares outstanding, 6.29M are free float. Of the floating shares, 11.16% have been sold short and that brings short ratio to 0.77.
Rennova Health, Inc. reported EPS for the last fiscal year and the current year’s EPS is expected to increase 66.70% over the previous year’s EPS.
The company’s next earnings date is scheduled for May 22/b.